6505--Buprenorphine Award

The Department of Veterans Affairs National Acquisition Center plans to issue a Request for Proposal (RFP 36E79726R0004) for the procurement of Buprenorphine HCL/Naloxone HCL tablets to serve the VA, Department of Defense, Bureau of Prisons, and Indian Health Service. This unrestricted contract aims to secure a single responsible vendor capable of providing a consistent supply of these medications. The contract will span one year, with four additional one-year options at pre-determined prices. Distribution will be managed through the VA’s and DOD’s Pharmaceutical Prime Vendor Programs, and the medications supplied must be labeled with a unique NDC number and not packaged in glass bottles. The solicitation will be issued electronically in commercial item format in early January 2026, with proposals due by mid-January 2026. The procurement falls under NAICS code 325412. Estimated annual requirements include approximately 171,239 bottles of the 2mg/0.5mg tablets and 251,144 bottles of the 8mg/2mg tablets, both in 30-count bottles. All documentation and amendments will be available for download online, with no paper copies provided. Interested offerors are encouraged to monitor the official procurement website regularly and direct any inquiries to the designated point of contact, Amber Zavala.